ClinicalTrials.gg
CompletedNCT05895071Updated Jun 8, 2023

Comparison of Topical 5%Potassium Hydroxide vs Liquid Nitrogen in the Treatment of Plane Warts

A Phase 1 interventional study of 5%potassium hydroxide and Liquid nitrogen in Plan Warts, sponsored by Combined Military Hospital Abbottabad. Completed at 1 site in Pakistan. Open to participants aged 4 Years to 30 Years. Per ClinicalTrials.gov, last updated 2023-06-08.

Sponsored by Combined Military Hospital Abbottabad · Phase 1, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Nov 2022, registered May 2023).
Phase
Phase 1
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
4 Years to 30 Years
Sex
All
01

Study summary

ABSTRACT Objective: To study the efficacy while comparing Potassium hydroxide 5% with liquid nitrogen in treatment of plane warts.

Study design: Randomized-controlled trial (RCT), (Double-blind). Study setting and duration: Dept dermatology, CMH-Abbottabad, Nov-2022 / April-2023.

Methodology: The sample size of 60 patients (children and adults aged 4 to 30 years) was calculated using Openepi app sample size RCT calculator, after informed consent by using non-probability consecutive sampling technique. Patients randomly assigned into two groups i.e. In group-A 30 patients were given topical 5%-potassium hydroxide solution on affected area once at night upto 4 weeks and in group-B 30 patients treated with cotton bud method of cryotherapy with liquid nitrogen once every two weeks. Patients were reassessed at every two weeks and final assessment was done at 12th week whereas followed up for 3 months to monitor recurrence. Demographic information and frequency percentages were calculated for qualitative variables by using SPSS26. To determine statistical significance taking p-value \<0.05 as significant, and χ2-square test was used.

02

Conditions studied

  • Plan Warts

Browse trials for

03

In context

Warts

171 studies on the registry are indexed under Warts; 35 are open to participants now.

This study's enrollment of 60 is below the median of 70 across 155 interventional studies indexed under Warts.

Browse Warts studies →

Lead sponsor

Combined Military Hospital Abbottabad is the lead sponsor of 25 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 4-30 years
  • Both males and females
  • Greater than 3 number of warts

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Breast feeding
  • Those who are taking immunosupressive drugs
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    Group A Topical 5% potassium hydroxide

    In group-A 30 patients were given topical 5%-potassium hydroxide solution on affected area once at night upto 4 weeks

    Drug: 5%potassium hydroxide

  • Active comparator
    Group B Liquid nitrogen

    in group-B 30 patients treated with cotton bud method of cryotherapy with liquid nitrogen once every two weeks. Patients were reassessed at every two weeks and final assessment was done at 12th week.

    Drug: Liquid nitrogen

Interventions

  • Drug5%potassium hydroxide

    . In group-A 30 patients were given topical 5% potassium hydroxide solution on affected area once at night for upto 4 weeks

  • in group-B 30 patients treated with cotton bud method of cryotherapy with liquid nitrogen once every two weeks. Patients were reassessed at every two weeks. The treatment carried out upto 12 weeks or until complete recovery from warts.

06

What researchers measure

Primary outcomes

  1. Comparative Efficacy of topical 5% Potassium hydroxide and liquid nitrogen in the treatment of plane warts

    Decrease in number or size of warts

    Time frame: 12 weeks

07

Study locations

1 site
  • Sana aslam
    Abbottabad, Khyber Pakhtun Khwaa 22010, Pakistan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05895071
Lead sponsor
Combined Military Hospital Abbottabad
Responsible party
Dr sana aslam (Principal investigator, Combined Military Hospital Abbottabad) — Principal investigator
First posted
Jun 8, 2023
Start date
Nov 1, 2022
Primary completion
Apr 30, 2023
Completion
Apr 30, 2023
Last update
Jun 8, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Nitrogen, liquid

Start the discussion